Correlation Between Valneva SE and Compass Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Compass Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Compass Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Compass Therapeutics, you can compare the effects of market volatilities on Valneva SE and Compass Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Compass Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Compass Therapeutics.

Diversification Opportunities for Valneva SE and Compass Therapeutics

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Valneva and Compass is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Compass Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compass Therapeutics and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Compass Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compass Therapeutics has no effect on the direction of Valneva SE i.e., Valneva SE and Compass Therapeutics go up and down completely randomly.

Pair Corralation between Valneva SE and Compass Therapeutics

Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Compass Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 1.29 times less risky than Compass Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Compass Therapeutics is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  453.00  in Compass Therapeutics on August 24, 2024 and sell it today you would lose (304.00) from holding Compass Therapeutics or give up 67.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Valneva SE ADR  vs.  Compass Therapeutics

 Performance 
       Timeline  
Valneva SE ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Valneva SE ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Compass Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Compass Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Compass Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Valneva SE and Compass Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Valneva SE and Compass Therapeutics

The main advantage of trading using opposite Valneva SE and Compass Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Compass Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compass Therapeutics will offset losses from the drop in Compass Therapeutics' long position.
The idea behind Valneva SE ADR and Compass Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account